China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
1.110
+0.050 (4.72%)
Apr 23, 2024, 12:48 PM EDT - Market open

China SXT Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016
Revenue
0.030.340.880.330.211.320.73
Revenue Growth (YoY)
-90.09%-61.68%167.83%55.75%-83.89%80.04%-
Cost of Revenue
-1.55-1.35-1.94-2.46-2.4-3.62-2.57
Gross Profit
1.581.692.822.792.614.933.3
Selling, General & Admin
6.036.445.044.042.841.770.71
Operating Expenses
6.036.445.044.042.841.770.71
Operating Income
-4.45-4.75-2.21-1.26-0.233.172.59
Interest Expense / Income
0.480.041.623.350.0100.04
Other Expense / Income
10.62-0.895.78-2.031.540.97
Pretax Income
-5.93-5.41-2.94-10.391.791.631.58
Income Tax
00.33-0.19-0.10.250.440.4
Net Income
-5.93-5.74-2.75-10.291.541.191.19
Net Income Growth
----29.61%0.21%-
Shares Outstanding (Basic)
0000000
Shares Outstanding (Diluted)
0000000
Shares Change
541.90%44.50%132.79%20.23%2.84%--
EPS (Basic)
-22.23-137.93-95.47-832.05149.50118.00118.00
EPS (Diluted)
-22.23-137.93-95.47-832.05149.50118.00118.00
EPS Growth
----26.69%0%-
Free Cash Flow
-0.150.21-1.410.53-0.360.890.11
Free Cash Flow Per Share
-0.574.95-48.9842.67-34.9789.0511.39
Gross Margin
4696.56%498.27%318.99%844.05%1231.48%374.69%451.26%
Operating Margin
-13249.91%-1401.12%-250.13%-380.06%-108.13%240.35%354.23%
Profit Margin
-17651.98%-1691.43%-310.53%-3113.48%725.52%90.17%162.01%
Free Cash Flow Margin
-450.44%60.69%-159.28%159.67%-169.51%67.61%15.57%
Effective Tax Rate
----14.08%27.04%25.00%
EBITDA
-5.13-5.05-0.98-6.711.981.761.72
EBITDA Margin
-15272.60%-1489.49%-110.74%-2030.37%932.13%133.47%235.11%
Depreciation & Amortization
0.320.320.350.330.180.130.1
EBIT
-5.46-5.37-1.33-7.041.81.631.62
EBIT Margin
-16233.89%-1583.85%-149.77%-2130.80%846.85%123.65%221.54%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).